CollabraLink Technologies is among the awardees of a $140 million Blanket Purchase Agreement from the Food and Drug Administration’s Center for Drug Evaluation & Research.
This new 5-year multiple-award vehicle will serve as a catalyst for a digital modernization initiative to automate key regulatory review processes spanning numerous CDER offices, the company said.
FDA leveraged a modern acquisition approach when issuing the WFM procurement. This was done in multiple stages and tested partners like CollabraLink to demonstrate their agile and UX processes and technical acumen via a prototype design challenge. The results from that challenge were then presented to FDA CDER stakeholders.
There’s no more important mission to the national agenda than to protect health via safe and effective drugs, said Mike Deutsch, CollabraLink chief growth officer.
“Improving business process management is a key pillar in CDER’s enterprise strategy, and this contract will help to facilitate improved health outcomes and quality of life for all Americans,” he added. “CollabraLink is honored to play a role in supporting FDA-CDER in the fulfillment of its vital mission objectives.”